Diligence memo · auto-generated · as of July 2, 2026
Jazz Pharmaceuticals Inc
Jazz Pharmaceuticals Inc has raised $209M over 4 rounds; too few niche peers to rank its valuation yet.
Businessfiled
Jazz Pharmaceuticals Inc operates in Pharmaceuticals, based in PALO ALTO.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Jazz Pharmaceuticals Inc has raised $209M in disclosed capital across 4 recorded rounds, aggregated from public filings. Its latest round is modeled as Series D+ (a $100M–$400M round).
Largest single filing: $120M on 2008-03-14.
Most recent recorded round closed around 2009-07-07.
Valuation (modeled)modeled
Provath models Jazz Pharmaceuticals Inc at approximately $247M (range $33M–$542M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Too few comparable companies in this niche to rank the valuation fairly yet.
Financing rhythm & timingmixed
Historic cadence: a new round about every 16 months.
Last raise 17.0 yr ago; this sector typically re-raises about every 13 months.
Silent for over 3× the sector's normal cadence.
The last round stepped up 3.5× from the prior — scaling.
Comparablesmixed
Capital scale ranks ahead of 97% of Pharmaceuticals peers (1613 compared).
Modeled value ranks above 71% of those peers.
Peoplefiled
18 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.